# New York Regional Center for Diabetes Translation Research

> **NIH NIH P30** · ALBERT EINSTEIN COLLEGE OF MEDICINE · 2022 · $98,184

## Abstract

Life Course Methodology Core
 The overall goal of the Life Course Methodology Core (LCMC) of the New York Regional Center for
Diabetes Translation Research is to support high quality type 2 translational research in diabetes prevention
and control across the life span. The life course perspective focuses on the biopsychosocial and behavioral
processes that individuals experience during particular periods in their life, and examines the interplay between
these exposures in shaping disease risk. Currently, there is strong evidence from observational studies that the
processes that lead to the development of diabetes start early in life and continue throughout the lifespan. This
life course approach also can enhance the translation of efficacious interventions by ensuring that intervention
strategies are appropriate for the age group targeted and address associated individual or environmental
barriers. Following this line of thought, we propose a two pronged approach that identifies the most relevant
modifiable risk factors and the most appropriate interventions taking into account the life stage targeted. The
LCMC will leverage existing multidisciplinary expertise and infrastructure to facilitate application of a life course
perspective to new translational diabetes research. Einstein investigators and their collaborators have
accumulated decades of expertise in diabetes research across the life span and are well positioned to
contribute to the acceleration of translational research. The LCMC will provide conceptual and instrumental
support regarding the design, and implementation of new translational diabetes research across the life span
with the ultimate goal of decreasing the burden of diabetes and alleviating diabetes health disparities. The
LCMC specific aims are: 1) To build capacity in using the life course approach to the design of new
translational diabetes research; 2) To facilitate the implementation of new translational diabetes research; 3)
To provide consultation and mentorship on biological factors underlying diabetes health disparities across the
lifespan.

## Key facts

- **NIH application ID:** 10480947
- **Project number:** 5P30DK111022-08
- **Recipient organization:** ALBERT EINSTEIN COLLEGE OF MEDICINE
- **Principal Investigator:** Carmen R. Isasi
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $98,184
- **Award type:** 5
- **Project period:** 2016-09-20 → 2026-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10480947

## Citation

> US National Institutes of Health, RePORTER application 10480947, New York Regional Center for Diabetes Translation Research (5P30DK111022-08). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10480947. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*